Literature DB >> 24633161

2013 Vulvodynia Guideline update.

Colleen K Stockdale1, Herschel W Lawson.   

Abstract

Vulvodynia is a complex disorder that can be difficult to treat. Most patients describe it as burning, stinging, irritation, or rawness. Vulvodynia is a costly disease both economically and on its negative impact on patient quality of life. Although many treatment options are available, no one treatment is effective for all patients, thus the need to individualize management. Measures such as gentle vulvar care, medication, biofeedback training, physical therapy, sexual counseling and surgery, as well as complementary and alternative therapies are available to treat the condition with varying success.

Entities:  

Mesh:

Year:  2014        PMID: 24633161     DOI: 10.1097/LGT.0000000000000021

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  22 in total

1.  Superficial dyspareunia.

Authors:  Kinshuk Kumar; Deborah Robertson
Journal:  CMAJ       Date:  2017-06-19       Impact factor: 8.262

2.  Vulvodynia, "A Really Great Torturer": A Mixed Methods Pilot Study Examining Pain Experiences and Drug/Non-drug Pain Relief Strategies.

Authors:  Judith M Schlaeger; Heather A Pauls; Keesha L Powell-Roach; Patrick D Thornton; Dee Hartmann; Marie L Suarez; William H Kobak; Tonda L Hughes; Alana D Steffen; Crystal L Patil
Journal:  J Sex Med       Date:  2019-06-14       Impact factor: 3.802

Review 3.  High-Intensity Laser Therapy (HILT) as an Emerging Treatment for Vulvodynia and Chronic Musculoskeletal Pain Disorders: A Systematic Review of Treatment Efficacy.

Authors:  Małgorzata Starzec-Proserpio; Marcela Grigol Bardin; Julie Fradette; Le Mai Tu; Yves Bérubè-Lauzière; Josianne Paré; Marie-Soleil Carroll; Mélanie Morin
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

4.  A Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled Trial.

Authors:  Martha F Goetsch; Jeong Y Lim; Aaron B Caughey
Journal:  J Clin Oncol       Date:  2015-07-27       Impact factor: 44.544

5.  Vestibular Mast Cell Density in Vulvodynia: A Case-Controlled Study.

Authors:  Dimitrios Papoutsis; Hope K Haefner; Christopher P Crum; Anthony W Opipari; Barbara D Reed
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

6.  Patterns in Vulvodynia Treatments and 6-Month Outcomes for Women Enrolled in the National Vulvodynia Registry-An Exploratory Prospective Study.

Authors:  Georgine Lamvu; Meryl Alappattu; Kathryn Witzeman; Mark Bishop; Michael Robinson; Andrea Rapkin
Journal:  J Sex Med       Date:  2018-04-07       Impact factor: 3.802

7.  The histopathological results of vestibulectomy specimens in localized provoked vulvodynia in Turkey.

Authors:  Suleyman Eserdag; Didem Kurban; Mine Kiseli; Murat Alan; Yasemin Alan
Journal:  Pan Afr Med J       Date:  2020-11-24

8.  Specialized Pro-resolving Mediators Reduce Pro-nociceptive Inflammatory Mediator Production in Models of Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; Ronald W Wood; Mitchell A Linder; Adrienne D Bonham; Kenneth V Honn; Krishna Rao Maddipati; Richard P Phipps; Constantine G Haidaris; David C Foster
Journal:  J Pain       Date:  2021-04-01       Impact factor: 5.383

9.  "You have to go through it and have your children": reproductive experiences among women with vulvodynia.

Authors:  Nora S Johnson; Eileen M Harwood; Ruby H N Nguyen
Journal:  BMC Pregnancy Childbirth       Date:  2015-05-15       Impact factor: 3.007

10.  Neonatal vaginal irritation results in long-term visceral and somatic hypersensitivity and increased hypothalamic-pituitary-adrenal axis output in female mice.

Authors:  Angela N Pierce; Zhen Zhang; Isabella M Fuentes; Ruipeng Wang; Janelle M Ryals; Julie A Christianson
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.